Relmada Therapeutics

-$1.09 (-5.55%) Today
$0.00 (0.00%) As of 8:16 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.

CEO
Sergio Traversa
Employees
10
Headquarters
Coral Gables, Florida
Founded
2012

RLMD Key Statistics

Market cap
556.33M
Price-Earnings ratio
—
Dividend yield
—
Average volume
315.75K
High today
$19.51
Low today
$18.11
Open price
$19.51
Volume
203.62K
52 Week high
$35.35
52 Week low
$15.74

RLMD Earnings

-$2.44
-$1.63
-$0.81
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure